As the landscape of American healthcare shifts, the once-frenzied expansion of Medicare Advantage is entering a period of sobering recalibration. With decades of experience navigating the labyrinth of federal healthcare policy and the strategic maneuvers of private insurers, our expert provides a
With the FDA's recent approval of a novel device-based therapy for pancreatic cancer, we're witnessing a fascinating convergence of physics, biology, and patient care. To unpack the significance of this milestone, we're joined by James Maitland, an expert in robotics and IoT applications in
With the midterm elections looming, the Department of Health and Human Services has become a key political battleground. In a significant move, Secretary Robert F. Kennedy Jr. recently appointed four senior officials to his inner circle, a decision aimed at accelerating the administration's "Make
In the high-stakes environment of cardiac care, where precision instruments can mean the difference between life and death, the reliability of medical technology is paramount. A significant safety concern has now emerged surrounding a critical device, as Johnson & Johnson's subsidiary, Abiomed,
A Regulatory Standoff with High Stakes In a move that sent shockwaves through the biotechnology sector, the U.S. Food and Drug Administration (FDA) has taken the extraordinary step of refusing to conduct a formal review of Moderna's biologics license application for its mRNA-based influenza
With the healthcare landscape in constant flux, the latest proposal from the Centers for Medicare & Medicaid Services aims to reshape the Affordable Care Act marketplaces. To help us understand these sweeping changes, we're speaking with James Maitland, a leading expert on U.S. health insurance
